The onset, severity, and ultimate outcome of malaria infection are influenced by parasite-expressed virulence factors as well as by individual host responses to these determinants. In both humans and mice, liver injury follows parasite entry, persisting to the erythrocytic stage in the case of infection with the fatal strain of Plasmodium falciparum. Hepatic nuclear factor (HNF)-1α is a master regulator of not only the liver damage and adaptive responses but also diverse metabolic functions. In this study, we analyzed the expression of host HNF-1α in relation to malaria infection and evaluated its interaction with the 5´-untranslated region of subtilisin-like protease 2 (subtilase, Sub2). Recombinant human HNF-1α expressed by a lentiviral vector (LV HNF-1α) was introduced into mice. Interestingly, differences in the activity of the 5´-untranslated region of the Pf-Sub2 promoter were detected in 293T cells, and LV HNF-1α was observed to influence promoter activity, suggesting that host HNF-1α interacts with the Sub2 gene.
Malaria, which is caused by infection with the hemoproto zoan parasite Plasmodium, afflicts approximately 500 million people each year, leading to 2.7 million deaths annually world wide [1] . Malaria infections result in diverse clinical outcomes, presumably because of the dynamic relationship between par asiteexpressed virulence factors and individual host responses to these determinants [2] . The last few years have seen a rapid growth in the number of reported genetic associations with host susceptibility and resistance to malaria; these are mainly variants in erythrocytes, cytoadherence factors, immune sys tem, and inflammatory genes [35] . However, the molecular basis of malaria infection remains incompletely defined. The identification of genetic factors involved in malaria susceptibil ity and resistance in both the host and the parasite would lead not only to a greater understanding of this complex disease but also potentially to development of effective medical inter ventions [2, 6] .
Interactions between Plasmodium and its host hepatocytic factors are of great research interest [79] . On one hand, it is well established that malaria sporozoites exploit signaling via the hepatocyte growth factor (HGF) and its receptor MET dur ing host invasion [10] . On the other hand, malaria is a life cy clespecific disease that includes liver injury at the erythrocytic stage of the parasite [11] . Indeed, both humans and mice suf fer from liver injury after infection with the fatal strains of Plas modium falciparum (Pf) and Plasmodium berghei (Pb) [12, 13] . Hepatic nuclear factor (HNF)1α, a liverspecific transcription factor also designated as LFB1 or TCF1, is a critical compo nent of the regulatory network, affecting diverse metabolic functions in the liver, pancreatic islets, intestine, and kidneys. The gene encoding HNF1α maps to chromosome 12q34 and functions as a dimer [14] . HNF1α plays an important role in transactivation of hepatic genes during adaptive responses to liver injury [15, 16] . Additionally, mutation in the gene is asso [16, 17] , indicating the important biological role of HNF 1α in glucose metabolism. In addition, HNF1α interacts with other transactivators to regulate the chromatin structure of the gene encoding the serine protease inhibitor, serpin [18] . P. fal ciparum subtilisinlike protease 2 (subtilase, Sub2) is an essen tial integral membrane serine protease in both Pf and Pb. It functions in shedding of the ectodomain components of 2 sur face proteins, membrane surface protein 1 (MSP1) and apical membrane antigen 1 (AMA1), upon host invasion [19, 20] . The importance of the Sub2 gene is evidenced by the fact that Sub2 knockout parasites cannot be recovered [21] .
In this study, to understand HNF1α interactions with the malaria antigen Sub2, the activity of the PfSub2 promoter was estimated. We cloned the 5´untranslated region (UTR) of Pf Sub2 from Pf genomic DNA (gDNA) and analyzed its tran scriptional activity when exogenous HNF1α was overexpressed in 293T cells.
Pf 3D7 strain was obtained from Malaria Research and Ref erence Reagent Resource Center (MR4; Manassas, Virginia, USA; http://www.mr4.org). Pf 3D7 culture conditions were set ac cording to the MR4 standard protocol. Parasitemia was calcu lated by counting at least 1,000 cells following staining with Diff Quik (Sysmex, Kobe, Japan). The parasitemia of about 10% to 30% was continuously maintained.
Cell culture media and components, including fetal bovine serum (FBS) were obtained from Invitrogen (Carlsbad, Cali fornia, USA). All cells were purchased from the American Type Culture Collection (ATCC, Rockville, Maryland, USA) and were routinely cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% FBS. HeLa and 293T cells were used for the experiments.
All plasmids were purified using JETstar2.0 mini and maxi prep Kit (GenoMed, St. Louis, Missouri, USA) according to the manufacturer's instructions. Pf 3D7 smallscale gDNA isola tion followed the MR4 protocol. The HNF1α cDNA clone was obtained from Open Biosystems (Accession No: BC104908; Rockford, Illinois, USA) and was amplified by PCR with prim ers F (5´ATAGAA TTCGCAGCCGAGCCATGGTTTCTA3´; EcoRI site underlined) and R (5´ATACTCGAGTGCCGTGGTTACT GGGAGGAAG3´; XhoI site underlined). The amplified frag ment was inserted into pCDNA3FlagHA (Addgene, Cambri dge, Massachusetts, USA) by EcoRI and XhoI ligation. Lentivi rus (LV) HNF1α was constructed by cutting the LV plasmid backbone with BamHI and XbaI to expel the resident luciferase gene, which was replaced with a HNF1α cDNA insert cut from pCDNA3HNF1αFlagHA. A construct for luciferase activity was based on a pGL3Basic vector (Promega, Madison, Wis consin, USA). Two different 5´upstream sequences flanking the PfSub2 gene were amplified from Pf 3D7 gDNA with pri mers. The primers used for 2,567/+32 UTR were F (5´ATAG GTACCTAGAATAGAATAAAATAAATAACC3´; KpnI site under lined) and R (5´ATAAAGCTTATCAAGGAAACCACATAA3´; HindIII site underlined). The primers used for 1,422/+12 UTR were F (5´AAGGTACCATGGTATGAGTTCTTTATA3´; KpnI site underlined) and R (5´ATGCTAGCAATATTCAGCATTATACG GA3´; NheI site underlined). PCR was performed using a TGR ADIENT thermocycler (Biometra, Goettingen, Germany). The amplified UTR sequences were cloned into a pMDT vector (Ta kara Bio, Shiga, Japan) and subcloned into a pGL3Basic vec tor with KpnI and NheI/HindIII sticky end ligation, generating the pGL3BasicPfSub2 5´UTR construct. The other upstream inserts were cloned into a pGL3Basic vector by blunt restric tion sites (EcoRV, SnaBI and SwaI) located in the 1.5kb region upstream of the luciferase gene. The internal control was pSV βgalactosidase (Promega). All clones were analyzed by restric tion mapping and were sequenced by a 3730XL DNA sequenc er (Macrogen, Seoul, Korea).
A human immunodeficiency virus (HIV)1based LV plas mid system, including the LV backbone with luciferase gene flanked at the 5´end by cytomegalovirus vector (CMV) pro moter, pCMV dR8.91 packaging construct, and pMDG2 enve lope plasmid, were kindly provided by Dr. Didier Trono. The pseudotyped LV was generated by cotransfecting these plas mids into 293T cells using the calcium phosphate method [22] . LV was concentrated by overlaying the viral supernatant on a 20% sucrose cushion and centrifuging at 12,000 rpm for 2 hr at 4˚C in a Beckman SW28 swing bucket rotor. Aliquots of the concentrated virus were stored at 80˚C. LV preparation quality was determined by using serial dilutions of the concentrated frozen viral stock to infect HeLa cells contained in 6well plates (NUNC, Roskilde, Denmark). After 48 hr incubation, lucifer ase activity of cells infected with 10 µL of a concentrated virus suspension was determined. The recombinant HNF1α was analyzed with an antiHNF1α antibody by western blotting as described below.
Fiveweekold mice were injected with LV HNF1α through the tail vein. The 200 µl injected volume varied in potency from a low dose consisting of 20 µl concentrated LV HNF1α and 180 µl of phosphatebuffered saline (PBS) to a high dose consisting of 200 µl of concentrated LV HNF1α. Blank control mice were injected with the same volume of PBS, and mimic control mice were injected with the LV backbone lacking HNF 1α. DNA isolated from liver tissue from LV HNF1αinfected mice was subjected to reverse transcription (RT)PCR with hu man HNF1αspecific primers that contained the maximum number of critical mismatches with the homologous mouse sequence (F: 5´CCCTGGCCTGCCTCCACCTG3´ and R: 5´GG GTCACATGGCTCTGCACAGGT3´).
Cells were harvested and lysed with RIPA buffer (Pierce, Rock ford, Illinois, USA) with freshly added protease inhibitor cock tail (SigmaAldrich, St. Louis, Missouri, USA). One hundred micrograms of cell lysate was diluted with a loading buffer that contained a reducing agent, and proteins were separated on 12% SDSPAGE and transferred to a polyvinylidene fluoride membrane. Immunoblotting was performed with a 1:200 di lution of rabbit polyclonal antiHNF1α antibody (SC10791; Santa Cruz Biotechnology, Santa Cruz, California, USA) in 3% bovine serum albumin (BSA). The secondary antibody, poly clonal goat antirabbit IgG conjugated with horseradish perox idase (HRP) (Dako, Glostrup, Denmark), was used at a 1:1,000 dilution in PBS. For proliferating cell nuclear antigen (PCNA) quantification, antiPCNA/HRP monoclonal antibody was used (Dako).
Cells were transfected with 2.5 µg of the reporter constructs and 0.5 µg of pCMVβgalactosidase by a standard calcium phosphate coprecipitation method in 6well plates. For co transfection, 1.5 µg of the reporter constructs and 0.5 µg of pCMVβgalactosidase were cotransfected with different amo unts of pCDNAHNF1αFlagHA (0.54.5 µg). Each sample was analyzed in duplicate and each experiment was repeated twice. Luciferase and βgalactosidase activities were measured using a model LB96V microplate luminometer (Berthold Tech nologies, Bad Wildbad, Germany) according to the manufac turer's instructions. Luciferase activity was normalized with re spect to βgalactosidase activity to correct deviation due to trans fection efficiencies and cell numbers. (Fig. 1A) . Six days following injection of LV backbone and LV HNF1α into mice, luciferase gene expression was detected in peripheral blood (data not shown). To confirm the expression of human HNF1α gene in mice, RTPCR was performed with mice liver tissues. Human HNF1α was amplified in mice infected with LV HNF1α but not in mice injected with the mimic LV backbone or PBS (Fig.  1B) .
To analyze the influence of HNF1α on the transcriptional activity of 5´UTR of PfSub2 in vitro, cotransfection of pGL3 BasicPfSub2 5´UTR with different amounts of HNF1α was performed in 293T cells. The exogenous HNF1α expression level of pCDNAHNF1αFlagHA in transfected 293T cells was ascertained by western blotting with antiHNF1α antibody (Fig. 2A) . High HNF1α expression was observed using 4.5 μg of the pCDNAHNF1αFlagHA transfection vector. Except for the 329/+12 UTR, the 5´UTRs showed high and distinct tran scriptional luciferase activities (Fig. 2B) . As the amount of pCD NAHNF1αFlagHA vector increased from 0.5 to 4.5 μg, lucif erase activity was increased. Although the 1,422/+12 UTR did not drive the luciferase activity in a similar manner as apparent in Fig. 2A , a significant difference was seen with 1.5 μg of pGL3 BasicPfSub2 5´UTR/4.5 μg of pCDNAHNF1αflagHA as compared with only 1.5 μg of pGL3BasicPfSub2 5´UTR. HNF1α is a critical regulator of diverse metabolic functions in the liver, pancreatic islets, intestine, and kidneys. It is essen tial for glucose, bile acid, and plasma cholesterol metabolism [15, 16, 23] . However, further details pertaining to HNF1α func tion remain to be resolved. HNF1α not only physically inter acts with basic transcriptional machinery, such as histone acet yltransferases (HATs), CREBbinding protein (CBP), and p300/ CBPassociated factor (P/CAF) [24] , but also plays an impor tant role in modulation of chromatin structure, as in the case of hyperacetylation of the serpin gene [18, 25] . Hence, exoge nous HNF1α signaling cascades might influence basic regula tory networks, metabolic states, and immune system function ing of the host, thereby indirectly influencing the infecting Plas modium. Since the molecular and cellular factors mediating differences in malaria virulence and severity are poorly under stood [26] , the present study might lay the groundwork for re search investigating different natural outcomes of malaria in fections.
The mechanism of HNF1α regulation in mammals is not fully understood. Moreover, clarifying transcription regulation in the Plasmodium genome is onerous because of the genome's abnormal ATrichness [27, 28] . Nonetheless, Plasmodium genes are organized similarly to those in eukaryotes and are also mo nocistronically transcribed [2931] , implying the presence of regulatory sequence elements flanking the coding regions [32, 33] . For example, the region upstream to the Pf multidrug re sistance gene can be induced at the transcriptional level by an timalarial drugs in chloroquinesensitive parasites [34] . Our results obtained from upstream transcriptional activities of Pf Sub2 demonstrate that the proximal promoter of PfSub2 is influenced by exogenous HNF1α. Although the effect of HNF 1α on malaria gene expression in cultured cells may be indi rect or atypical, the present results indicate the feasibility of regulation of genes important for malaria invasion via host parasite interaction.
The present study has shown that exogenous human HNF 1α expression is involved in host response to malaria infec tion. Interestingly, host HNF1α interacts at the mRNA level with the parasite serine protease Sub2, which is important in host cell invasion by the malarial parasite. Specific upstream regions are important in the activity of the protease. Taken to gether, these data suggest that human HNF1α interacts with the promoter regions of the Sub2 gene. Future studies will be aimed at elucidating the role of HNF1α in malaria sensitivity/ resistance and how Sub2 gene expression is influenced by the host HNF1α signaling cascade. 
